What is Aarti Drugs Limited (AARTIDRUGS) share price today?

Aarti Drugs Limited (AARTIDRUGS) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/AARTIDRUGS for the latest live price, technical analysis, and AI-powered insights.

How to analyse AARTIDRUGS stock?

VestAI provides comprehensive AARTIDRUGS stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Aarti Drugs Limited in?

Aarti Drugs Limited (AARTIDRUGS) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

Aarti Drugs Limited

Q: What is Aarti Drugs Limited's Orion Score?

Aarti Drugs Limited has an Orion Score of 55/100 (Watch) — a fundamentals-based quality & risk score. Aarti Drugs Limited scores 55/100 (Watch) on the Orion Score — moderate business quality (62), poor growth (24), moderate balance-sheet safety (63) and cheap valuation (67). A fundamentals-based quality & risk score, not a buy/sell recommendation.

AARTIDRUGS

NSE· Healthcare

₹396.80

+1.45 (+0.37%)

Updated 12:29 pm IST

52W Low · ₹322.0552W High · ₹564.05

Mid Range

Market Cap

₹3621.59L Cr

Volume

76.8K

Prev Close

₹395.35

ISIN

INE767A01016

Orion Score

Fundamentals-based quality & risk · not a recommendation

55/100

Watch

Aarti Drugs Limited scores 55/100 (Watch) on the Orion Score — moderate business quality (62), poor growth (24), moderate balance-sheet safety (63) and cheap valuation (67). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 1.2× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 6/9Altman Z Safe(6.76)Beneish M Clean(-2.49)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

37/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.37x — lean balance sheet

QUALITY

Average

ROCE 12.8% — decent returns

MOMENTUM

Bullish

RSI 63.0 — strong momentum

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 18.52
ROCE: 12.80%
ROE (1Y): 13.36%
D/E Ratio: 0.37x
OPM: 10.80%
TTM EPS: ₹21.43
Dividend Yield: 51.00%
Qtrly Sales: ₹720.30 Cr
Qtrly Profit: ₹55.19 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹720.3	₹55.19	10.8%	₹6.05
Q3 2026	₹601.71	₹40.54	6.2%	₹4.44
Q2 2026	₹652.79	₹45.28	10.4%	₹4.95
Q1 2026	₹590.51	₹53.91	10.1%	₹5.91
Q4 2025	₹676.76	₹62.86	11.6%	₹6.88

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹2,565.31	₹194.92	₹311.58	9.4%
FY 2025	₹2,387.03	₹168.16	₹303.42	9.7%
FY 2024	₹2,508.87	₹171.42	₹320.49	11.1%
FY 2023	₹2,705.57	₹166.31	₹307.8	9.8%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
AARTIDRUGS ★	₹3,622 Cr	18.52	12.80%	13.36%	0.37x	10.80%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,029 Cr	25.94	12.55%	9.93%	0.21x	15.11%
ABBOTINDIAAbbott India Limited	₹57,724 Cr	36.63	36.14%	34.46%	0.04x	27.01%
AJANTPHARMAjanta Pharma Limited	₹41,836 Cr	39.55	27.99%	25.39%	0.06x	51.40%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹2,574.68	₹2,432.36	₹2,421.4	₹2,207.96
Equity	₹1,369	₹1,281.55	₹1,192.43	₹1,036.36
Total Debt	₹615.07	₹564.28	₹608.91	₹542.82
Cash	₹4.58	₹6.74	₹7.5	₹21.61
Net Debt	₹607.67	₹555.67	₹599.02	₹516.73
Working Capital	₹501.39	₹525.18	₹542.31	₹453.31

Shareholding Pattern

Q1 FY2027

Promoter

60.16%

FII

6.12%

DII

5.01%

Public

28.71%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	60.16% ↓	6.12% ↑	5.01% ↑	28.71% ↑
Q4 FY2026	61.23% ↑	6.08% ↑	4.98% ↓	27.71% ↓
Q3 FY2026	55.03% ↑	2.15% ↓	10.12% ↑	32.71%
Q2 FY2026	54.72% ↓	2.68% ↑	9.9% ↓	32.7% ↑
Q1 FY2026	55.23% ↓	2.26%	9.94% ↑	32.58%
Q4 FY2025	55.48% ↑	2.25% ↓	9.7% ↑	32.57% ↓
Q3 FY2025	55.38% ↓	2.28% ↓	8.77% ↑	33.58% ↓
Q2 FY2025	55.64%	2.5%	7.83%	34.01%

Corporate Actions

Ex-Date	Action	Details
2026-02-09	DIVIDEND	Interim Dividend - Rs 2 Per Share

Funds Holding This Stock

9 mutual fund schemes

DSP Small Cap Direct Plan GrowthDSP

1.32%

₹242 Cr

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct GrowthICICI_PRUDENTIAL

1.10%

₹71 Cr

DSP Healthcare Fund Direct GrowthDSP

0.98%

₹32 Cr

Bandhan BSE Healthcare Index Fund Direct GrowthIDFC

0.09%

₹0 Cr

Bandhan Nifty Total Market Index Fund Direct GrowthIDFC

0.01%

₹0 Cr

Motilal Oswal BSE 1000 Index Fund Direct GrowthMOTILAL_OSWAL

0.01%

₹0 Cr

Groww Nifty Total Market Index Fund Direct GrowthINDIABULLS

0.01%

₹0 Cr

Mirae Asset Nifty Total Market Index Fund Direct GrowthMIRAE_ASSET

0.01%

₹0 Cr

Angel One Nifty Total Market Index Fund Direct GrowthAngel One

0.01%

₹0 Cr

Analyse AARTIDRUGS with Orion AI

Ask: "Is Aarti Drugs Limited stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Aarti Drugs Limited (AARTIDRUGS) Stock

Aarti Drugs Limited is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE767A01016. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.